Copyright
©The Author(s) 2002.
World J Gastroenterol. Dec 15, 2002; 8(6): 987-993
Published online Dec 15, 2002. doi: 10.3748/wjg.v8.i6.987
Published online Dec 15, 2002. doi: 10.3748/wjg.v8.i6.987
Table 2 Expression of E-cadherin or β-catenin and Gross Ap-pearance
No | E-cadherin expression (%) | β-catenin expression (%) | |||
Abnormal | P value | Abnormal | P value | ||
Tumor size (cm) | 163 | ||||
0-4.9 | 48 | 16 (33.3) | 14 (28.2) | ||
5.0-9.9 | 76 | 30 (35.5) | 16.58 | 29 (36.2) | 21.41 |
≥ 10.0 | 39 | 29 (74.4) | < 0.005a | 30 (78.9) | < 0.005a |
Gross appearance | 139 | ||||
BorrmannI | 12 | 1 (8.3) | 2 (16.7) | ||
BorrmannII | 16 | 3 (18.8) | 3 (18.8) | ||
BorrmannIII | 80 | 35 (43.8) | 11.92 | 32 (40.0) | 9.65 |
BorrmannIV | 31 | 21 (67.7) | < 0.005b | 24 (77.4) | < 0.005b |
- Citation: Zhou YN, Xu CP, Han B, Li M, Qiao L, Fang DC, Yang JM. Expression of E-cadherin and β-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival. World J Gastroenterol 2002; 8(6): 987-993
- URL: https://www.wjgnet.com/1007-9327/full/v8/i6/987.htm
- DOI: https://dx.doi.org/10.3748/wjg.v8.i6.987